ResMed's S7 Elite CPAP combines integrated humidification, data for both patients and clinicians, and a number of other features that produce optimal comfort, convenience, and patient involvement in ...

The market feared that would reduce demand for ResMed’s various CPAP airflow machines, which patients wear during sleep to relieve the condition. Such selloffs have generally been buying ...

ResMed’s CPAP (continuous positive airway pressure) product, the AirFit N20. The California-based company, founded by Mr Farrell’s father in Sydney 35 years ago, is also listed on the ASX.

[Image courtesy of ResMed] ResMed (NYSE: RMD) + announced today that it launched its new AirTouch N30i continuous positive airway pressure (CPAP) mask. ResMed says it developed the AirTouch N30i ...

Many analysts see GLP-1 drugs, which have shown positive results in treating sleep apnea, as a threat to CPAP companies. But ResMed, which makes sleep apnea devices, sees an opportunity.

With interactive coaching and nightly sleep data tracking, MyAir helps increase CPAP usage, with 87% of patients achieving therapy compliance. (ResMed also launched a new CPAP mask today — read ...

NEW YORK — The morning after presenting an upbeat outlook to analysts in a gilded hall in the New York Stock Exchange building, Mick Farrell, the CEO of ResMed, looked refreshed, despite a post ...

such as the AirTouch N30i next-generation CPAP mask unveiled earlier today. Capitalize on ResMed’s market opportunity and brand advantage in broader sleep health and breathing health adjacencies ...